These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2210166)

  • 1. [Torsade de pointes induced by quinidine: a case treated successfully with verapamil].
    Ometto R; Arfiero S; Vincenzi M
    G Ital Cardiol; 1990 May; 20(5):431-4. PubMed ID: 2210166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
    Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
    Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of isoproterenol on quinidine induced torsade de pointes.
    Yamamoto H; Bando S; Nishikado A; Shinohara A; Hamai K; Yamamoto K; Ikefuji H; Ito S
    Tokushima J Exp Med; 1991 Jun; 38(1-2):1-4. PubMed ID: 1948996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
    Hii JT; Wyse DG; Gillis AM; Cohen JM; Mitchell LB
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 1):1568-70. PubMed ID: 1721143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].
    Karch M; Schmitt C; Plewan A; Schmidt G; Schömig A
    Herz; 1997 Feb; 22(1):51-6. PubMed ID: 9173039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged quinidine half-life with associated toxicity in a patient with hepatic failure.
    Stanek EJ; Simko RJ; DeNofrio D; Pavri BB
    Pharmacotherapy; 1997; 17(3):622-5. PubMed ID: 9165569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female preponderance in ibutilide-induced torsade de pointes.
    Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
    Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of quinidine and verapamil in auricular fibrillation].
    Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
    Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
    Assimes TL; Malcolm I
    Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short coupled variant of torsade de pointes: our experience and review of the literature].
    Fehri W; Abdessalem S; Smiri Z; Mhenni H; Barakett N; Rahal N; Haouala H
    Tunis Med; 2004 Sep; 82(9):867-74. PubMed ID: 15693481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long QT syndrome induced by cordaron and quinidine].
    Mironchik EV; Dolgosheĭ TS; Liskovich TG; Madeshkina GA; Kokhkovski AB; Tyshchenko AD
    Klin Med (Mosk); 2007; 85(3):69-71. PubMed ID: 17523411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes induced by short-term oral amiodarone therapy.
    Lim HE; Pak HN; Ahn JC; Song WH; Kim YH
    Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.